TLR9 and B-cell chronic lymphocytic leukemia: Concurrently, the apoptotic rate of CD5hiCXCR4low proliferation cells did not decrease in our experiments; only the TLR9 agonist CpG gave rise to a reduced apoptotic rate of l-CLL cells.